MaxLinear enters the final days of May with a new and sharper tension: the analyst community has begun aggressively ratcheting targets higher, yet the stock at $96 has already blown past nearly every number being published.
The Street action this week is the standout. Benchmark initiated fresh coverage on May 27 with a Buy and a $125 target — the highest published number on the stock and the only one that actually sits above where shares are trading today. That followed a wave of post-earnings upgrades in late April: Loop Capital lifted its rating to Buy and more than quadrupled its target from $17 to $75; Needham upgraded to Buy with a $60 target; Stifel maintained Buy and raised to $49. The mean target across all analysts has converged around $58 — a figure the stock cleared weeks ago and now trades roughly 65% above. That gap tells a clear story: the Street is still playing catch-up to a price that moved violently and fast. Benchmark's $125 is the first target that reflects current reality, and analyst-recommendation divergence scores in the 89th percentile, suggesting there is still meaningful disagreement about where this belongs.
Options positioning reinforces the bullish lean, but with slightly less intensity than a week ago. The put/call ratio is 0.26 — more than 1.3 standard deviations below its 20-day average of 0.58 — keeping call positioning at one of the most lopsided readings of the past year. The ratio has barely moved since mid-May, when it dropped sharply from around 0.75. That persistence is notable; it is not a one-day enthusiasm spike. The lending market remains completely untroubled: availability is at 5,045%, meaning roughly 50 shares remain available to borrow for every one currently lent out. Cost to borrow dropped sharply to just 0.18% on May 26, down from around 0.50% all week — further confirmation that no short-side pressure is building. SI % of Free Float is essentially flat on the week at 4.5%, well off the mid-April peak near 7%. The short-covering story that drove much of the initial rally has run its course.
Insider activity deserves a mention, though it is not a new development. CEO and founder Kishore Seendripu sold 33,682 shares at $96.77 on May 20, raising roughly $3.3 million — following a similar pattern of selling across multiple insiders throughout the month. Principal Accounting Officer Connie Kwong sold again on May 25. These are award-related sell programmes rather than discretionary disposals, but the volume has been consistent. On a 90-day net basis, insiders show a net positive of roughly 309,000 shares when awards are included, but the cash disposals have been steady at elevated prices.
Peer performance adds context to the week's pullback. MXL fell 3.1% on Tuesday while close peers SYNA and QCOM gained 2.7% and 4.5% respectively on the same day, and SIMO climbed 5.1%. On the week MXL is up 1.3%, lagging SIMO at +21% and SYNA at +24%. The relative underperformance in a strong tape for the group is worth watching — the broader semiconductor cohort is moving sharply and MXL is not keeping up on an intraday basis.
The next formal test is the Q2 earnings call scheduled for July 22. Given that the last print sent the stock up 78% in a session, and the one before that added 100% over five days, the question then becomes whether the current price already reflects the earnings recovery that drove those moves — or whether the Keystone PAM4 ramp still has numbers left to deliver.
See the live data behind this article on ORTEX.
Open MXL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
